Last reviewed · How we verify

NCT03951922

Occupational Therapy and Horticulture for Cancer Survivors With Chronic Pain

Completed NA Last updated 13 March 2020
What this trial tests

NA trial testing Horticultural activity in Cancer Survivor in 9 participants. Completed in 10 February 2020.

Timeline
8 June 2019
Primary endpoint
23 November 2019
10 February 2020

Quick facts

Lead sponsorLoma Linda University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment9
Start date8 June 2019
Primary completion23 November 2019
Estimated completion10 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Loma Linda University

Who can join

Adults 18 to 64, any sex, with Cancer Survivor or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this quasi-experimental study is to explore the impact of a therapeutic horticulture program as an occupation-based intervention to address chronic pain symptoms for cancer survivors. The main objectives are to assess participants' perceptions of pain, physical and psychosocial wellness, stress management, and quality of life at pre-, post-, and 3-month follow-up. Quantitative and qualitative data will be synthesized and analyzed to explore this phenomenon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Horticultural activity

Trials testing the same drug.

Other recruiting trials for Cancer Survivor

Currently open trials in the same condition.

Other Loma Linda University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03951922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing